EPISODE · Mar 26, 2021 · 22 MIN
TBD | The AstraZeneca Saga
from What Next | Daily News and Analysis
Back in April 2020, AstraZeneca was hailed as a frontrunner in the race to get an effective vaccine to market. A year later, after a series of trial pauses, communication blunders, and PR problems, the vaccine is on the cusp of FDA approval. By all accounts, the company succeeded in making a safe, effective vaccine. So why has there been so much confusion about its rollout?Guest: Peter Aldhous, science reporter at Buzzfeed NewsHostLizzie O’Leary Hosted on Acast. See acast.com/privacy for more information.
What this episode covers
Back in April 2020, AstraZeneca was hailed as a frontrunner in the race to get an effective vaccine to market. A year later, after a series of trial pauses, communication blunders, and PR problems, the vaccine is on the cusp of FDA approval. By all accounts, the company succeeded in making a safe, effective vaccine. So why has there been so much confusion about its rollout?Guest: Peter Aldhous, science reporter at Buzzfeed NewsHostLizzie O’Leary Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
TBD | The AstraZeneca Saga
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m